论文部分内容阅读
目的探讨疏血通联合依达拉奉治疗老年脑梗死患者的效果。方法选取2015年2月至2016年6月瓦房店市中心医院收治的老年脑梗死患者81例为研究对象,根据治疗方法不同分为研究组和对照组,对照组40例患者单纯接受依达拉奉治疗,研究组41例患者采用疏血通联合依达拉奉治疗,比较两组患者的治疗效果。结果研究组患者的总有效率为95.1%,明显高于对照组的72.5%,差异有统计学意义(P<0.05);对照组患者不良反应发生率为22.5%,研究组为4.9%,差异有统计学意义(P<0.05);研究组患者治疗后各项生命质量指标评分均明显优于对照组,差异均有统计学意义(均P<0.05)。结论疏血通联合依达拉奉治疗老年脑梗死患者临床价值高,具有疗效显著、安全性高、预后好等优势。
Objective To investigate the effect of Shuxuetong combined with edaravone in the treatment of elderly patients with cerebral infarction. Methods A total of 81 elderly patients with cerebral infarction who were admitted to Wafangdian Central Hospital from February 2015 to June 2016 were selected as study subjects and divided into study group and control group according to different treatment methods. Laval treatment, 41 patients in the study group were treated with Shuxuetong combined with edaravone, and the treatment effect was compared between the two groups. Results The total effective rate of the study group was 95.1%, which was significantly higher than that of the control group (72.5%, P <0.05). In the control group, the incidence of adverse reactions was 22.5% and that of the study group was 4.9% (P <0.05). The score of each quality of life index of the study group was significantly better than that of the control group (all P <0.05). Conclusion Shuxuetong combined edaravone treatment of elderly patients with cerebral infarction clinical value, with significant efficacy, safety, good prognosis and other advantages.